A Study Of Upper Extremity Sequential Compression Sleeve

Overview

About this study

The purpose of this study is to establish that a newly designed UE sequential compression sleeve and pneumatic pump device will be safe, tolerable and effective when applied to the upper extremity.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Healthy Adults with intact skin, sensation, range of motion, strength and cognition.

  • Able to provide informed consent by self-agreement.

  • Aged 18 or older.

Exclusion Criteria:

  • Inability to give consent by self-agreement due to questionable cognitive reliability.

  • Pain in the UE. 

  • Impaired sensation, range of motion (wrist/hand/elbow), strength

  • Recent injury to the UE

  • PICC Line, existing IV, AV fistula or AV graft, recent skin graft.

  • Recent surgery on UE or vein ligation.

  • UE DVT, or axillary/subclavian DVT.

  • Open or active UE wounds or infection.

  • UE ischemia, gangrene, severe arteriosclerosis.

  • Status Post lymph nodes axillary dissection following breast cancer or melanoma surgery on UE.

  • CHF exacerbation, acute edema of unknown etiology in UE, Acute Kidney Injury, unstable BP.

  • Extreme deformity of the arm.

  • Acute edema of unknown etiology in the UE.

  • Subjects under 18.

  • Women confirmed pregnant.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 05/07/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

C Yelvington, P.T., D.P.T.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions